Sanofi-Aventis U.S. LLC recalls Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation…
- Recall date
- September 1, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0704-2017
- FDA classification
- Class III
- Brand / firm
- Sanofi-Aventis U.S. LLC
- Sold / distributed
- Nattionwide
Why it was recalled
Labeling: Incorrect or Missing Package Insert
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street, Cambridge, MA 02412 USA NDC: 0024-5862-01
Get recall alerts
Free email alert whenever Sanofi-Aventis U.S. LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sanofi-Aventis U.S. LLC